How to Help Your Patients Find Fenofibrate in Stock: A Provider's Guide

"My pharmacy doesn't have it." This is a phrase providers hear from fenofibrate patients with increasing regularity. While no national FDA shortage exists in 2026, localized pharmacy-level availability gaps are a real issue that can interrupt treatment for patients managing high triglycerides or mixed dyslipidemia. This guide gives you practical, ready-to-use strategies to help your patients stay on therapy.

Why Pharmacy-Level Gaps Happen With Fenofibrate

Understanding the root cause helps you prescribe around the problem. Fenofibrate availability gaps at individual pharmacies are primarily caused by:

• A single pharmacy contracting with one generic manufacturer — if that manufacturer has a production delay, the pharmacy runs out
• The wide variety of fenofibrate formulations (10+ strengths across tablets and capsules) means a pharmacy may stock one strength but not another
• Smaller pharmacies carry less inventory and may not reorder proactively
• Brand-name versions (Tricor, Lipofen, Antara) are increasingly hard to find at retail; patients prescribed brand names may need to switch to generic explicitly

Strategy 1: Be Flexible With Fenofibrate Formulations at the Point of Prescribing

The most powerful thing you can do at the point of care is write a prescription that gives the pharmacy flexibility. Consider:

• Prescribe generic (dispense as written off): Allow the pharmacist to dispense any FDA-approved generic equivalent. This opens up all available generic manufacturers.
• Write for the most common strengths: Generic fenofibrate 145 mg tablets (Tricor equivalent) and 160 mg tablets are the most widely stocked. If your patient's clinical needs allow, prescribing these strengths maximizes availability.
• Avoid specifying brand names unless medically necessary: Brand-name Tricor, Lipofen, and Antara have very limited retail availability. Unless there is a clinical reason to specify a brand, writing the generic name gives pharmacists the most options.

Strategy 2: Direct Patients to Mail-Order Pharmacy

For patients on long-term fenofibrate therapy, mail-order pharmacy is often the most reliable and cost-effective option. Mail-order pharmacies:

• Carry large, consistent inventory of common generics like fenofibrate
• Dispense 90-day supplies, reducing the frequency of refill issues
• Often cost less per pill than retail pharmacies (especially for patients on commercial insurance or Medicare Part D)

Write a 90-day supply prescription when switching patients to mail-order. Check whether your patient's plan requires a specific mail-order vendor (Express Scripts, OptumRx, CVS Caremark are the most common).

Strategy 3: Use medfinder to Help Locate Stock Near the Patient

When a patient needs their medication urgently and cannot wait for mail-order, medfinder is a practical tool to recommend. Patients enter their medication details and zip code, and medfinder calls local pharmacies to check which ones have the medication in stock. Results are texted directly to the patient.

This is especially valuable because fenofibrate stock varies so much by specific strength and formulation. A patient looking for 160 mg tablets may find that a pharmacy two miles away has plenty while their usual location is empty. medfinder surfaces that information without requiring the patient to make a dozen phone calls.

Strategy 4: Have a Ready Clinical Alternative

For patients who are truly unable to find their fenofibrate, having a clinical fallback ready avoids treatment gaps. Here is a quick clinical decision tree:

• Patient not on a statin → Gemfibrozil 600 mg twice daily is a reasonable bridge
• Patient on a statin, primary issue is high TG → Prescription omega-3 fatty acids (icosapentaenoic acid 4 g/day preferred; or omega-3-acid ethyl esters)
• Patient on a statin, primary issue is elevated LDL → Consider maximizing statin dose or adding ezetimibe 10 mg
• Patient with severe TG ≥ 500 mg/dL → Prioritize finding fenofibrate or gemfibrozil (if not on statin); this population is at risk for pancreatitis

Strategy 5: Proactively Switch Long-Term Patients to 90-Day Mail-Order

For patients who have been on fenofibrate long-term and have experienced stock-out issues more than once, consider proactively switching them to a 90-day mail-order supply. This eliminates most future availability issues and often saves the patient money. During their next visit (or via a portal message), update their prescription to specify:

• 90-day supply per fill
• Allow generic substitution
• Route to their insurance plan's preferred mail-order pharmacy

Summary: Provider Checklist for Fenofibrate Availability Issues

1. Prescribe generic fenofibrate with substitution allowed
2. Prefer common strengths: 145 mg or 160 mg tablets when clinically appropriate
3. Route chronic patients to mail-order pharmacy for 90-day fills
4. Direct patients to medfinder.com to locate their specific formulation at nearby pharmacies
5. Have a clinical alternative ready based on statin use and primary lipid abnormality